Meropenem Prodrugs (Kyoto Pharmaceutical Industries)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMeropenem Prodrugs (Kyoto Pharmaceutical Industries)
Drug Alias NameKL-3713KL-3745KL-3756KL-3774KL-3746 +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyoto Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyoto Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A